EdgarLookup

YOUNG JAMES F

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to YOUNG JAMES F. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

NVAX
Company Title Type Shares Price Value Date
NVAX Sale 4,600 $8.48 $39,008 Dec 31, 2024
NVAX Sale 7,500 $14.09 $105,675 Jun 21, 2024
NVAX Sale 1,107 $14.28 $15,808 Jun 18, 2024
NVAX Option Exercise 6,670 Jun 12, 2024
NVAX Option Exercise 4,600 Jun 10, 2023
NVAX Option Exercise 1,400 Jun 17, 2022
NVAX Sale 300 $75.10 $22,530 Mar 31, 2022
NVAX Sale 3,750 $144.16 $540,600 Dec 31, 2021
NVAX Option Exercise 10,000 Jul 1, 2021
NVAX Option Exercise 7,590 Jun 25, 2021
NVAX Sale 4,434 $227.43 $1,008,425 Mar 23, 2021
NVAX Sale 2,000 $113.60 $227,200 Jan 1, 2021
NVAX Purchase 1,500 $48.83 $73,245 Jun 3, 2020
NVAX Sale 175,000 $1.06 $185,500 Aug 31, 2017
NVAX Sale 100,000 $1.39 $139,000 Mar 14, 2017
NVAX Sale 50,000 $9.47 $473,500 Jun 18, 2015
NVAX Purchase 25,000 $4.47 $111,750 Mar 25, 2014
NVAX Purchase 100,000 $1.91 $191,000 Jun 6, 2013
NVAX Purchase 100,000 $2.03 $203,000 Mar 11, 2013
NVAX Purchase 200,000 $1.46 $292,000 Dec 1, 2011
0000873591 President, R&D U 13,695 $58.00 $794,310 Jun 4, 2007
0000873591 President, R&D Option Exercise 8,640 $2.75 $23,760 Feb 3, 2006
0000873591 President, R&D Sale 8,640 $32.62 $281,837 Feb 3, 2006